GlobalData on MSN2d
Ascletis announces positive results in Phase Ib oral GLP-1RA trial
The Hong Kong company saw a reduction in body weight across both cohorts with no serious adverse events reported.
Medscape2d
GLP-1s and Nutrition: A Paradigm Shift Toward Quality and Sustainable Health
GLP-1s and nutrition: quality over restriction! Dr Almandoz shares how shifting from restrictive diets to evidence-based, ...
GlobalData on MSN2d
GLP-1RAs and opioid use disorder: a new frontier in addiction treatment
Glucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...
Many adults stop GLP-1 therapy within a year with low restart rates, analysis finds
A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults ...
Medscape2d
Compounded GLP-1s: Navigating the Telemedicine Landscape and Ensuring Patient Safety
Are compounded GLP-1s safe? Dr Ro breaks down the risks, FDA concerns, and telemedicine's role in prescribing these meds — what physicians must know to protect their patients.